Form 4: RenovoRx Director Acquires Stock Options
SEC Form 4 Filing
Robert J. Spiegel, a director of RenovoRx, Inc., acquired 25,099 stock options on October 1, 2024, according to a Form 4 filing with the SEC.
Summary
- Robert J. Spiegel, a director of RenovoRx, Inc., filed a Form 4 with the SEC.
- The transaction occurred on October 1, 2024.
- Spiegel acquired 25,099 stock options with an exercise price of $1.02.
- The options vest in 12 equal monthly installments starting November 1, 2024.
- The options expire on October 1, 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director acquiring stock options suggests confidence, but it's a routine transaction.
Positives
- A director's acquisition of stock options can be seen as a positive signal, indicating confidence in the company's future.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation.
Stakeholder Impact
- The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 10/01/2024 | Date of stock options transaction |
| 10/01/2024 | Date of earliest transaction |
| 10/02/2024 | Date of signature |
| 11/01/2024 | Vesting start date for stock options |
| 10/01/2034 | Expiration date for stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.